Spot-light on microbiota in obesity and cancer

Int J Obes (Lond). 2021 Nov;45(11):2291-2299. doi: 10.1038/s41366-021-00866-7. Epub 2021 Aug 6.

Abstract

Over the last few years, the complexity and diversity of gut microbiota within and across individuals has been detailed in relation to human health. Further, understanding of the bidirectional association between gut microbiota and metabolic disorders has highlighted a complimentary, yet crucial role for microbiota in the onset and progression of obesity-related cancers. While strategies for cancer prevention and cure are known to work efficiently when supported by healthy diet and lifestyle choices and physical activity, emerging evidence suggests that the complex interplay relating microbiota both to neoplastic and metabolic diseases could aid strategies for cancer treatment and outcomes. This review will explore the experimental and clinical grounds supporting the functional role of gut microbiota in the pathophysiology and progression of cancers in relation to obesity and its metabolic correlates. Therapeutic approaches aiding microbiota restoration in connection with cancer treatments will be discussed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Gastrointestinal Microbiome / immunology*
  • Gastrointestinal Microbiome / physiology*
  • Gastrointestinal Tract / metabolism
  • Humans
  • Metabolic Diseases / metabolism
  • Neoplasms / epidemiology
  • Neoplasms / etiology*
  • Neoplasms / physiopathology
  • Obesity / complications*
  • Obesity / epidemiology
  • Obesity / physiopathology